Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of $0.12, versus ($0.18) reported last year. Revenue for the quarter came in at $169 thousand, versus $75 thousand reported last year.

For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.